Resilience for Young People With ADHD - a Randomized Controlled Trial of a Brief Intervention Program.
Launched by UNIVERSITY OF AARHUS · Aug 18, 2014
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
The complete CONSORT trial protocol is available at http://myresilience.org/ at the subsite 'about us'.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- A random sample with 8.000 patients registered in the Danish National Patient Register:
- • Age 18-27
- • ADHD diagnosis
- Exclusion Criteria:
- • • Request for legal protection against contacts from researchers.
Trial Officials
Poul L Bak
Principal Investigator
University of Aarhus
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
